Chronic kidney disease (CKD) represents a global public health crisis, but awareness by patients and providers is poor. Defined as persistent abnormalities in kidney structure or function for more than three months, manifested as either low glomerular filtration rate or presence of a marker of kidney damage such as albuminuria, CKD can be identified through readily available blood and urine tests. Early recognition of CKD is crucial for harnessing major advances in staging, prognosis, and treatment. This review discusses the evidence behind the general principles of CKD management, such as blood pressure and glucose control, renin-angiotensin-aldosterone system blockade, statin therapy, and dietary management. It additionally describes individualized approaches to treatment based on risk of kidney failure and cause of CKD. Finally, it reviews novel classes of kidney protective agents including sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, non-ste
Voting ends this Sunday for our SXSW panel Who Gives A Sh!t About Marketing Live Music
hypebot.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hypebot.com Daily Mail and Mail on Sunday newspapers.
SXSW panels worth voting for from Bandsintown, Rock Paper Scissors, The Orchard & more
hypebot.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hypebot.com Daily Mail and Mail on Sunday newspapers.
Vote for our SXSW panel Who Gives A Sh!t About Marketing Live Music
hypebot.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hypebot.com Daily Mail and Mail on Sunday newspapers.